A detailed history of Cutler Group LP transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Cutler Group LP holds 700 shares of APLT stock, worth $609. This represents 0.0% of its overall portfolio holdings.

Number of Shares
700
Holding current value
$609
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 19, 2024

BUY
$2.25 - $7.4 $1,575 - $5,180
700 New
700 $4,000
Q2 2022

Aug 04, 2022

SELL
$0.76 - $2.64 $167 - $580
-220 Closed
0 $0
Q1 2022

Apr 14, 2022

BUY
$1.48 - $6.22 $325 - $1,368
220 New
220 $0

Others Institutions Holding APLT

About Applied Therapeutics Inc.


  • Ticker APLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,020,700
  • Market Cap $41.8M
  • Description
  • Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...
More about APLT
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.